Loomis Sayles & CO L P Catalent, Inc. Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $4.24 Million - $8.95 Million	-133,121 Reduced 90.87%	13,380 $580,000
Q1 2023 May 11, 2023	SELL	$45.44 - $74.26 $493,342 - $806,240	-10,857 Reduced 6.9%	146,501 $9.63 Million
Q4 2022 Feb 10, 2023	SELL	$41.39 - $81.0 $946,216 - $1.85 Million	-22,861 Reduced 12.69%	157,358 $7.08 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $1.31 Million - $2.04 Million	-18,036 Reduced 9.1%	180,219 $13 Million
Q2 2022 Aug 05, 2022	SELL	$87.2 - $114.05 $59,383 - $77,668	-681 Reduced 0.34%	198,255 $21.3 Million
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $21.5 Million - $28.4 Million	-228,113 Reduced 53.42%	198,936 $22.1 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $21.1 Million - $24.6 Million	-176,789 Reduced 29.28%	427,049 $54.7 Million
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $8.12 Million - $10.6 Million	-74,413 Reduced 10.97%	603,838 $80.4 Million
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $644,483 - $743,076	-6,423 Reduced 0.94%	678,251 $73.3 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $8.93 Million - $11 Million	-88,000 Reduced 11.39%	684,674 $72.1 Million
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $2.82 Million - $3.46 Million	32,848 Added 4.44%	772,674 $80.4 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $148,316 - $188,607	2,039 Added 0.28%	739,826 $63.4 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $7.14 Million - $11.7 Million	-148,652 Reduced 16.77%	737,787 $54.1 Million
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $2.21 Million - $3.77 Million	59,836 Added 7.24%	886,439 $46.1 Million
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $1.83 Million - $2.2 Million	-38,919 Reduced 4.5%	826,603 $46.5 Million
Q3 2019 Nov 13, 2019	BUY	$47.45 - $58.05 $3.77 Million - $4.62 Million	79,535 Added 10.12%	865,522 $41.3 Million
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $6.24 Million - $8.61 Million	158,861 Added 25.33%	785,987 $42.6 Million
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $735,735 - $1.08 Million	-24,656 Reduced 3.78%	627,126 $25.5 Million
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $353,410 - $546,812	-11,800 Reduced 1.78%	651,782 $20.3 Million
Q3 2018 Nov 13, 2018	SELL	$40.12 - $45.55 $930,463 - $1.06 Million	-23,192 Reduced 3.38%	663,582 $30.2 Million
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $322,808 - $354,489	-8,337 Reduced 1.2%	686,774 $28.8 Million
Q1 2018 May 11, 2018	SELL	$39.4 - $47.39 $3.45 Million - $4.15 Million	-87,598 Reduced 11.19%	695,111 $28.5 Million
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $677,978 - $782,576	18,191 Added 2.38%	782,709 $32.2 Million
Q3 2017 Nov 14, 2017	SELL	$33.75 - $41.67 $2.26 Million - $2.79 Million	-67,015 Reduced 8.06%	764,518 $30.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	831,533	831,533 $29.2 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

Vanguard Group Inc Valley Forge, PA

20.2M
Shares

$1.28 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

15.4M
Shares

$975 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$473 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$406 Million
0.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$287 Million
0.14% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account